These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
4. Pathogenetic treatments for diabetic peripheral neuropathy. Ziegler D Diabetes Res Clin Pract; 2023 Dec; 206 Suppl 1():110764. PubMed ID: 38245327 [TBL] [Abstract][Full Text] [Related]
5. Diagnostic Tools, Biomarkers, and Treatments in Diabetic polyneuropathy and Cardiovascular Autonomic Neuropathy. Bönhof GJ; Herder C; Ziegler D Curr Diabetes Rev; 2022; 18(5):e120421192781. PubMed ID: 33845748 [TBL] [Abstract][Full Text] [Related]
6. Current concepts in the management of diabetic polyneuropathy. Ziegler D Curr Diabetes Rev; 2011 May; 7(3):208-20. PubMed ID: 21534920 [TBL] [Abstract][Full Text] [Related]
7. Pathogenesis, diagnosis and clinical management of diabetic sensorimotor peripheral neuropathy. Sloan G; Selvarajah D; Tesfaye S Nat Rev Endocrinol; 2021 Jul; 17(7):400-420. PubMed ID: 34050323 [TBL] [Abstract][Full Text] [Related]
8. Critical appraisal of the use of alpha lipoic acid (thioctic acid) in the treatment of symptomatic diabetic polyneuropathy. McIlduff CE; Rutkove SB Ther Clin Risk Manag; 2011; 7():377-85. PubMed ID: 21941444 [TBL] [Abstract][Full Text] [Related]
9. Current Pharmacological Treatment of Painful Diabetic Neuropathy: A Narrative Review. Ardeleanu V; Toma A; Pafili K; Papanas N; Motofei I; Diaconu CC; Rizzo M; Stoian AP Medicina (Kaunas); 2020 Jan; 56(1):. PubMed ID: 31936646 [No Abstract] [Full Text] [Related]
10. Frontiers in diagnostic and therapeutic approaches in diabetic sensorimotor neuropathy (DSPN). Sharma S; Rayman G Front Endocrinol (Lausanne); 2023; 14():1165505. PubMed ID: 37274325 [TBL] [Abstract][Full Text] [Related]
11. Whither pathogenetic treatments for diabetic polyneuropathy? Boulton AJ; Kempler P; Ametov A; Ziegler D Diabetes Metab Res Rev; 2013 Jul; 29(5):327-33. PubMed ID: 23381942 [TBL] [Abstract][Full Text] [Related]
12. Neuropathic pain is not adequately treated in the older general population: Results from the KORA F4 survey. Meisinger C; Bongaerts BWC; Heier M; Amann U; Kowall B; Herder C; Rückert-Eheberg IM; Rathmann W; Ziegler D Pharmacoepidemiol Drug Saf; 2018 Jul; 27(7):806-814. PubMed ID: 29797371 [TBL] [Abstract][Full Text] [Related]
14. Painful and painless neuropathies are distinct and largely undiagnosed entities in subjects participating in an educational initiative (PROTECT study). Ziegler D; Landgraf R; Lobmann R; Reiners K; Rett K; Schnell O; Strom A Diabetes Res Clin Pract; 2018 May; 139():147-154. PubMed ID: 29518491 [TBL] [Abstract][Full Text] [Related]
15. Redefining distal symmetrical polyneuropathy features in type 1 diabetes: a systematic review. Galosi E; Hu X; Michael N; Nyengaard JR; Truini A; Karlsson P Acta Diabetol; 2022 Jan; 59(1):1-19. PubMed ID: 34213655 [TBL] [Abstract][Full Text] [Related]
16. Advances in the diagnosis and management of diabetic distal symmetric polyneuropathy. Kasznicki J Arch Med Sci; 2014 May; 10(2):345-54. PubMed ID: 24904671 [TBL] [Abstract][Full Text] [Related]
17. Treatment of diabetic polyneuropathy: Update 2006. Ziegler D Ann N Y Acad Sci; 2006 Nov; 1084():250-66. PubMed ID: 17151306 [TBL] [Abstract][Full Text] [Related]
18. Burning through the pain: treatments for diabetic neuropathy. Javed S; Alam U; Malik RA Diabetes Obes Metab; 2015 Dec; 17(12):1115-25. PubMed ID: 26179288 [TBL] [Abstract][Full Text] [Related]
19. Pathways in the diagnosis and management of diabetic polyneuropathy. Kaku M; Vinik A; Simpson DM Curr Diab Rep; 2015 Jun; 15(6):609. PubMed ID: 25899758 [TBL] [Abstract][Full Text] [Related]
20. A brief overview of the diabetic neuropathies. Boulton AJM Diabetes Res Clin Pract; 2023 Dec; 206 Suppl 1():110758. PubMed ID: 38245328 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]